Total Funding
4
Total FundingDebt Financing raised
Growth Score
pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Vyteris is a pharmaceutical company manufacturing products that deliver drugs through the skin using low-level electrical energy.
About the Company
Vyteris is the maker of the first active drug delivery patch to receive market approval from the U.S. Food and Drug Administration (FDA). Vyteris was organized in November 2000 as a spinout of the Transdermal Systems unit of Becton Dickinson and Company (BD), to develop, manufacture, and commercialize pharmaceutical products based upon this unique,
advanced drug delivery technology. BD created Transdermal Systems just prior to 1990 and invested 10 years and close to $80 million in developing the basis of the Vyteris transdermal drug delivery system.
